TOP STORIES

• REGULATORY New Minister Has Hopes for Pharma Industry in Both Medical and Economic Fronts, Wants to Balance Innovation and Cost
  August 29, 2017

• REGULATORY Opdivo’s Gastric Cancer Use, Avelumab and More Up for MHLW Panel Review/Report on Sept. 8
  August 28, 2017

• BUSINESS Spinraza to Hit Japan Market on August 30
  August 28, 2017

• REGULATORY MHLW Seeks 31.4 Trillion Yen in FY2018 Budget, 630 Billion Yen in Natural Rise for Social Security
  August 25, 2017

• REGULATORY Livalo Successor Parmodia Skips August Listing as Price Negotiation Hits Snag, Celgene’s Istodax Too
  August 24, 2017

• REGULATORY Spinraza’s 9.32 Million Yen Price Tag OK’ed for Listing on Aug. 30
  August 23, 2017

• BUSINESS External Activities of Takeda Unit Axcelead to Go Full Throttle This Autumn: President
  August 23, 2017

• TRENDS Japan Generic Market Decelerating, 3 Majors Log Only Slight Uptick in April-June
  August 22, 2017

• REGULATORY MHLW Study Group to Expand Investigation to Clinics to Determine Causes of Improper Promotional Activities
  August 22, 2017

• REGULATORY Clinical Research Law to Apply to Indirectly Funded Programs Too, MHLW to Clarify Procedures: Official
  August 21, 2017

• TRENDS Pharmas’ Rep Number Corrections in Full Force amid Bleak Market Outlook, Silver Lining Seen in “Specialty” Arena
  August 18, 2017

• BUSINESS Harvoni Top-Selling Drug in Japan in FY2016, Opdivo Jumps but Drop Expected for FY2017: Jiho Tally
  August 17, 2017

• ACADEMIA Japan Gastric Cancer Association to Wait for Opdivo Nod before Guidelines Update, Keytruda Won’t Make It This Time
  August 16, 2017

• REGULATORY 11 Firms Get Approval for Irbesartan Generics towards December Listing, including AG; 26 Flock to Crestor
  August 16, 2017

• REGULATORY NIBIOHN to Promote Drug Discovery in Fields with Unmet Needs by Automating Target Discovery Using AI
  August 15, 2017

• INTERVIEW Me Pharma Sees Opportunities in Low-Cost Strategy, Could Carve Out New Biz Models: President
  August 14, 2017

• REGULATORY Calls Growing for Tougher Requirements to Receive Price Maintenance Premium: Chuikyo
  August 10, 2017

• BUSINESS Growth of Global Products Outstrips Abilify Drop in Jan.-June: Otsuka
  August 9, 2017

• BUSINESS Astellas Looks to Be First to Market in HIF-PH Inhibitor Space
  August 8, 2017

• ACADEMIA NCCHD to Launch Panel to Study Real-World Drug Use in Children, Findings Might Be Used for Label Revisions
  August 8, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• 168
• …
• Next ›
• 最終 »